Jill Wechsler The Food and Drug Administration (FDA) has been encouraging manufacturers to demonstrate how process knowledge and full understanding of critical product parameters can ensure drug quality. Such quality by design (QbD) approaches offer potential benefits and savings for manufacturers, as well as the prospect of regulatory relief. Officials...

Link to Article

BioPharm International -- Advanstar Communications Inc